Repositorio Dspace

A Multicentre, 4-Year Mirror-Image Study Comparing the Effectiveness of Long-Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study.

Mostrar el registro sencillo del ítem

dc.contributor.author García-Carmona, Juan-Antonio
dc.contributor.author Barnett, Joshua
dc.contributor.author Campos-Navarro, María-Pilar
dc.contributor.author Mason, Katie
dc.contributor.author Simal-Aguado, Jorge
dc.contributor.author Pappa, Sofía
dc.date.accessioned 2026-04-20T09:45:31Z
dc.date.available 2026-04-20T09:45:31Z
dc.date.issued 2026-02
dc.identifier.citation García-Carmona JA, Barnett J, Campos-Navarro MP, Mason K, Simal-Aguado J, Pappa S. A Multicentre, 4-Year Mirror-Image Study Comparing the Effectiveness of Long-Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study. Bipolar Disorders. febrero de 2026;28(1):e70080. doi:10.1111/bdi.70080
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/25957
dc.description.abstract BACKGROUND: This was a 4-year mirror-image study of adult patients diagnosed with bipolar disorder (BD) assessing the effects on treatment continuation and hospitalisation between aripiprazole 1-month (A1M), risperidone-LAI (R-LAI) and the monthly and 3-monthly formulations of paliperidone palmitate (PP1M, PP3M). We aimed to evaluate and compare the use of A1M, R-LAI, and the monthly and 3-monthly formulations of paliperidone palmitate (PP1M, PP3M) by using the change of number and length of hospitalisations 2years before compared to 2years after initiation of LAIs for continuers and discontinuers. Secondary outcomes were: (1) discontinuation rates at 2years and reasons per LAI, (2) time to discontinuation per LAI, and (3) time to first hospitalisation per LAI.RESULTS: A total of 122 BD were included; 74 continued LAI treatment at two years. Reasons for discontinuation were poor compliance (50%), ineffectiveness (43.2%), and tolerability issues (13.6%). Both time to individual LAI discontinuation and time to first hospital admission were significantly lower in the R-LAI group. There was a significant overall reduction in the number and length of hospitalisations two years before and after LAI initiation, although multivariate logistic regression analysis showed that A1M, PP1M and R-LAI were associated with an increased risk (OR=1.89, 95% CI=1.54-3.68, p=0.015; OR=1.63, 95% CI=1.29-2.77, p=0.022; OR=3.08, 95% CI=1.48-6.05, p=0.008, respectively) of bed usage compared to PP3M. Last, study completers showed a considerable drop of 79% in number of hospital admissions and 83% in bed days (p=0.001) as opposed to non-completers.CONCLUSIONS: Study findings suggest that long-acting antipsychotics such as A1M, PP1M, and particularly PP3M are associated with high retention and lower hospitalisation rates after 2years of treatment in patients with BD.
dc.language.iso eng
dc.publisher WILEY
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Bipolar Disorder/drug therapy
dc.subject.mesh Antipsychotic Agents/administration & dosage/therapeutic use
dc.subject.mesh Female
dc.subject.mesh Male
dc.subject.mesh Adult
dc.subject.mesh Middle Aged
dc.subject.mesh Treatment Outcome
dc.subject.mesh Delayed-Action Preparations
dc.subject.mesh Paliperidone Palmitate/administration & dosage/therapeutic use
dc.subject.mesh Aripiprazole/administration & dosage/therapeutic use
dc.subject.mesh Hospitalization/statistics & numerical data
dc.subject.mesh Risperidone/administration & dosage/therapeutic use
dc.title A Multicentre, 4-Year Mirror-Image Study Comparing the Effectiveness of Long-Acting Injectable Antipsychotics in the Treatment of Bipolar Disorder: Results From the LAICO Study.
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 41631553
dc.relation.publisherversion https://onlinelibrary.wiley.com/doi/10.1111/bdi.70080
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1111/bdi.70080
dc.journal.title Bipolar disorders
dc.identifier.essn 1399-5618


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta